Cardinal Health Inc. (CAH)
Cardinal Health, Inc. (CAH) Hit a 52 Week High, Can the Run Continue?
Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
3 Reasons Why Growth Investors Shouldn't Overlook Cardinal (CAH)
Cardinal (CAH) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Will Cardinal (CAH) Beat Estimates Again in Its Next Earnings Report?
Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Why the Market Dipped But Cardinal Health (CAH) Gained Today
In the latest trading session, Cardinal Health (CAH) closed at $208.26, marking a +2.83% move from the previous day.
Cardinal Health, Inc. (CAH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Cardinal Health, Inc. (CAH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Cardinal Health Stock Jumps on Guidance Raise. Why 2026 Will Be a Good Year.
The healthcare services company says it expects to bring in over $50 billion in specialty revenue in fiscal 2026.
Should Value Investors Buy Cardinal Health (CAH) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Buy These 5 Dividend Growth Stocks Amid Conflicting Labor Market Data
Dividend-growth stocks like CAH stand out as labor data sends mixed signals, offering income stability and growth amid economic uncertainty.
3 Medical Supplies Stocks That Beat the Market Despite Macro Headwinds
Cardinal Health, McKesson, and Cencora are showing how scale, specialty focus, and execution can drive market-beating returns despite macro pressure.
Why Cardinal Health (CAH) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
